Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Boston Children’s is a world leader in opening new avenues of “translational research,” bringing laboratory advances to the bedside and doctor’s office as quickly as possible. Dr. Jonas, medical director of the Liver Transplant Program, has led research focused on liver disease in children with emphasis on viral hepatitis. Her recent work includes investigations into the treatment of hepatitis B and C viruses in children. She was the principal investigator in the multicenter international pediatric lamivudine trial and the multicenter trial of adefovir dipivoxil, in which the drugs, which are effective in adults with chronic hepatitis B, were tested in children. Dr. Jonas's work has been published in the New England Journal of Medicine, Hepatology, Pediatric Infectious Disease Journal and other major medical journals.
Faculty members of the Liver Transplant Program are also currently involved in NIH-sponsored research studies: SPLIT (Studies of Pediatric Liver Transplantation) and PEDS-C (Peginterferon with and without ribavirin for children with chronic hepatitis C).
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”